Canadian company to be exclusive supplier of broadband wireless mesh equipment for 40 communities under construction. - May 15, 2008 - Tranzeo Wireless Technologies

NexTech Solutions, Inc. and FAS Holdings Group, LLC, jointly doing business as “NexTechFAS”, are pleased to announce that the company has been invited to present at the SID/Cowen and Company Display Investors Conference on May 20 and 21, 2008. - May 08, 2008 - NexTechFAS

Former Ericsson Senior Vice President joins Tranzeo Wireless Technologies as Director. - May 03, 2008 - Tranzeo Wireless Technologies

SX ReadyCal 1001 Promotional Film Specially Engineered for Screen Printing. - April 20, 2008 - Avery Dennison Graphics

Telkoor Telecom (TASE: TLK) the global provider of power supplies, for military, industrial and telecom applications today announced that its subsidiary in Israel, Telkoor Power Supplies Ltd. has entered into a non-exclusive manufacturing license & Sales agreement with Murata Power Solutions. Under... - April 04, 2008 - Telkoor Power Supplies Ltd.

So Unique a Huckleberry Liqeuer. - March 28, 2008 - Liquor Group

First New Agent for CLL Patients Approved by the FDA since 2001 - March 21, 2008 - Cephalon

Company says it's progressing steadily on audits, funding and revenue, prepares for the Bulletin Board. - March 13, 2008 - Brunton Vineyards

CEAT Ltd, the flagship company of the 13,500 crore RPG Group and one of India’s leading tyre manufacturers has today signed an agreement with M/s. Ashford InfoTech Limited for development of a vacant portion of about 7 acres of land located at Village Road in Bhandup, Mumbai. The proceeds of the... - March 12, 2008 - RPG

The FDA has approved PRISTIQ (desvenlafaxine), an SNRI, to treat adult patients with major depressive disorder (MDD). Wyeth expects to begin shipping PRISTIQ to wholesalers beginning in the second quarter of 2008. - March 01, 2008 - Wyeth Pharmaceuticals

Partnership combines Proximetry’s AirSync intelligent provisioning and management software with Tranzeo’s carrier-class wireless products to better serve vertical and developing markets. - February 02, 2008 - Tranzeo Wireless Technologies

NVIDIA® has enabled the ultimate gaming notebooks with the most powerful graphics processing solution available for notebook PCs—a combination of NVIDIA SLITM technology and two NVIDIA GeForce® 8800M GTX GPUs. GeForce 8800M GTX GPUs, the world’s highest performance notebook graphics... - January 30, 2008 - NVIDIA

RJK Explorations (RJX.A) is considering Cuban mining opportunities. - January 24, 2008 - RJK Explorations Ltd.

Simulated Environment Concepts, Inc. (SMEV). | Effective January 16, 2008 the trading company’s name, 5th Avenue Channel Corp. was changed to Simulated Environment Concepts, Inc. In addition, effective immediately, the old symbol FAVE is replaced with a new symbol SMEV. As part of this corporate... - January 20, 2008 - Simulated Environment Concepts, Inc.

RJK Explorations Ltd. (RJX.A) has intersected a higher grade gold zone in the latest drilling program on the Goldie Gold Property. One intersection was .261 oz gold per ton over 6.6 ft. - January 12, 2008 - RJK Explorations Ltd.

Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals

Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan Pharmaceuticals... - January 09, 2008 - Samaritan Pharmaceuticals

The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health is... - January 03, 2008 - Samaritan Pharmaceuticals

Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals

The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the participating... - December 30, 2007 - RPG

New Wine Club built to accommodate sports fans as wine company targets NASCAR, IRL, NBA, NFL and Boating as an aggressive distribution strategy. - December 29, 2007 - Brunton Vineyards

•Rs. 391 Crores win in Abu Dhabi; Largest single win ever, in dollar value terms, for KEC •Rs. 246 crores turnkey contract in Algeria - December 01, 2007 - RPG

•Rs. 260 Crores Turnkey contract in Saudi Arabia •Rs. 140 Crores Turnkey contract in Namibia - December 01, 2007 - RPG

In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals

BioRenewable Chemicals Corporation to focus on ethanol derivative chemicals as an alternative to petroleum based compounds. Industrial Biotechnology Corporation (OTC Pink Sheets: IBTY) (IBC), a company dedicated to new biotechnologies and innovations in the chemical industry, announces the divestiture... - October 24, 2007 - Industrial Biotechnology Corporation

Telkoor Telecom (TASE: TLK) the global provider of power supplies, for military, industrial and telecom applications today announced that its subsidiary in Israel has received a repeat order of $1.3M from a major defense customer in United States. The subsidiary will provide two types of power supplies... - October 23, 2007 - Telkoor Power Supplies Ltd.

Amidst massive recalls on products made in China, American Metal strives to make a name for itself based on quality. - October 19, 2007 - American Metal & Technology

In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson

Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals

Iconix Brand Group (NASDAQ: ICON) announced today to commemorate the 125th anniversary of its Danskin® brand, it has unveiled the Heritage Collection, a limited edition line of iconic Danskin dancewear and activewear styles updated with luxury fabrics. Each design is a celebration of its timeless... - September 05, 2007 - Danskin, Inc.

Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals

A recording of the Market News First interview with President and C.E.O., Kenneth P. Pavlich, is now available on the Market News First web site (www.MN1.com). - June 20, 2007 - El Capitan Precious Metals, Inc.

Telkoor Telecom has announced that its subsidiary in Israel has received a NIS 2.7 million order for the development and manufacture of a unique airborne system. The order received specifies that the system will be developed next year while production will begin in 2009. In addition, the firm was informed... - June 15, 2007 - Telkoor Power Supplies Ltd.

Meade Instruments Corp. (Nasdaq NM: MEAD), today announced the launch of its newest product, mySKY™, the first integrated, full color, easy-to-use, handheld multimedia guide for sky exploration. “Since its founding in 1970, Meade has built a reputation for creating innovative products that... - April 12, 2007 - Meade Instruments

SIMCO Industrial Static Control has recently been award a patent for their new True AC Static Control Power Supply. - March 20, 2007 - SIMCO Industrial Static Control

Barco, a leading global provider of visual display solutions, has recently brought digital 3D projection to the La Géode giant dome in Paris.  La Géode is one of the largest geodesic domes in the world and the Barco installation makes this exhibit the largest 3D digital presentation... - March 17, 2007 - Barco Simulation

Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis

In insomnia news, actor and insomnia sufferer, Cheryl Hines, joins the American Academy of Nurse Practitioners (AANP) Foundation to pull the covers off chronic insomnia. “Why Count on Sheep to Sleep?”, an educational initiative, supported by Sanofi-Aventis, raises awareness of sleep problems, causes of insomnia, and provides people with sleep solutions. Sleep disorders can be a serious medical condition characterized by difficulty falling asleep and staying asleep. - March 10, 2007 - Sanofi-Aventis

Pro-Tect, Inc. (PRTT.PK) announced today that it has entered into a licensing agreement with American Natural Technology Sciences (ANTS) for the marketing rights to Mitigator's® technology. - March 09, 2007 - Pro-Tect, Inc.

Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to fighting cancer: Engaging the immune system to attack cancer in the same the way it would a flu vaccine, by creating... - February 27, 2007 - Advaxis

Barco, a world leader in high-performance image processing and visual display systems, today announced that Lockheed Martin has selected its advanced video processing technology for the F-35 Lightning II Joint Strike Fighter training program. Barco’s technology will be incorporated into the F-35... - February 23, 2007 - Barco Simulation

Brooks RFID Division will present its RFID solutions at a number of different trade fairs. - February 20, 2007 - Brooks Automation (Germany) GmbH - Featured Press Release

Carrington Laboratories, Inc. (Nasdaq: CARN) announced it has entered into a one-year endorsement and personal services agreement with racing legend Johnny Rutherford. The partnership provides a platform for Carrington to reach the rapidly growing and attractive racing enthusiast consumer market. Under... - February 17, 2007 - Carrington Laboratories

Wine Company Prepares to Launch new Wine Drink to NASCAR fans during the Summer - February 16, 2007 - Brunton Vineyards